HLLY:NYSEHolley Inc. Analysis
Data as of 2026-04-08 - not real-time
$2.92
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Holley Inc. (HLLY) is trading at $2.92, well below its 20‑day ($3.02), 50‑day ($3.62) and 200‑day ($3.39) simple moving averages, indicating a technical discount that aligns with a RSI of 37 and a bullish MACD histogram (+0.04). The stock sits on a support level around $2.70 and faces resistance near $3.37, while volume has been trending down, suggesting limited short‑term buying pressure but also a potential for a bounce if fundamentals hold. On the fundamentals side, the company delivered a 10.9% YoY revenue growth to $613.5 M and improved net income to $6.3 M, yet earnings per share missed consensus ($0.04 vs $0.09), creating a mixed earnings narrative. Valuation metrics are attractive – a trailing PE of 18.3, a forward PE under 7, a price‑to‑book of 0.77 and a price‑to‑sales of 0.57 – pointing to a significant upside potential reflected in the 76.9% upside/downside estimate. However, the balance sheet is strained, with a debt‑to‑equity ratio above 124 and net debt far exceeding cash, which dampens profitability (ROE 4.4%) and raises liquidity concerns. The recent acquisition of HRX expands Holley's safety and racing apparel line, potentially diversifying revenue streams and supporting the growth narrative in a high‑volatility, high‑beta (1.43) consumer‑cyclical sector.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Price near technical support with bullish MACD histogram
- Revenue beat and 10.9% YoY sales growth
- Earnings miss creates short‑term price pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Acquisition of HRX broadens product portfolio
- Forward PE under 7 suggests strong valuation upside
- Consistent revenue growth despite cyclical environment
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio limits financial flexibility
- Cyclical consumer‑cyclical sector exposure
- Brand strength and diversification potential from recent acquisitions
Key Metrics & Analysis
Financial Health
Revenue Growth11.00%
Profit Margin3.13%
P/E Ratio18.3
ROE4.41%
ROA4.65%
Debt/Equity124.89
P/B Ratio0.8
Op. Cash Flow$46.2M
Free Cash Flow$9.6M
Technical Analysis
TrendNeutral
RSI37.4
Support$2.70
Resistance$3.37
MA 20$3.02
MA 50$3.62
MA 200$3.39
MACDBullish
VolumeDecreasing
Fear & Greed Index84.96
Valuation
Target Price$5.17
Upside/Downside76.94%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.19
Volatility66.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.